IRCT20230222057495N12
Recruiting
未知
Bioequivalence study of famotidine 40 mg tablets of Ramopharmin pharmaceutical company compared to Famotidine 40 mg of Ratiopharm GmbH in Germany on healthy volunteers.
Ramopharmin Pharmaceutical Company0 sites24 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Ramopharmin Pharmaceutical Company
- Enrollment
- 24
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Healthy volunteer between 18 and 55 years old.
- •Body mass index less than 30 kg per square meter.
- •All candidates must be non\-smokers.
Exclusion Criteria
- •Blood pressure less than 90 on 60 mm Hg or more than 140 on 90 mm Hg.
- •Consumption of any drug, alcohol or tobacco within 2 weeks before receiving the drug
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Bioequivalence study of famotidine 40 mg tablets produced by Actoverco pharmaceutical companyThis study is performed on healthy volunteers and drug concentration in plasma is determined..IRCT20240804062647N1?Actoverco Pharmaceutical Company24
Completed
Not Applicable
Bioequivalance study of Famotidine 40 mgIRCT20200513047423N5Fatak chemie pars Pharmacy24
Not yet recruiting
Not Applicable
Bioequivalance study of Famotidine 40 mgSubject: Bioequivalence of Famotidine 40 mg Tablet and Comparison of Pharmacokinetic Parameters with Ratiopham Reference Tablet.IRCT20200513047423N9Iran Daru Pharmaceutical Company24
Recruiting
Not Applicable
Bioequivalence study of Famotidine 40 mg tabletIRCT20210519051345N32Tabriz University of Medical Sciences24
Not yet recruiting
Not Applicable
Bioequivalence study of Famotidine 40 mgIRCT20200623047902N14Sanamed pharma company24